16
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T28865 |
STAT3-IN-B9
STAT3 IN B9,B9 |
STAT | JAK/STAT signaling; Stem Cells |
STAT3-IN-B9 (B9) 是异常 STAT3 激活的抑制剂,可抑制 MDA-MB-468、MDA-MB-231 和 DU145 等肿瘤细胞的增殖。 | |||
T82579 |
Dermaseptin-B9
|
||
Dermaseptin-B9为Phyllomedusinae亚科青蛙分离得到的一种抗菌肽。 | |||
TQ0009 |
UCB9608
|
PI4K | PI3K/Akt/mTOR signaling |
UCB9608 是选择性、可口服的 PI4KIIIβ 抑制剂,IC50=11 nM,对其选择性高于 PI3KC2 α,β 和 γ。它能够增加代谢稳定性,具有良好的药代动力学特征,是一种免疫抑制剂。 | |||
T13112L1 |
Tat-NR2B9c acetate
Tat-NR2B9c acetate (500992-11-0 Free base),NA-1 acetate |
Others | Others |
Tat-NR2B9c acetate (NA-1 acetate) 是一种突触后密度 95 (PSD-95) 抑制剂,对 PSD-95d2 (PSD-95 PDZ domain 2) 和 PSD-95d1 的 EC50 值分别为 6.7 nM 和 670 nM。它破坏 PSD-95/NMDAR 相互作用,抑制 NR2A 和 NR2B 与 PSD-95 的结合,IC50 值分别为 0.5 μM 和 8 μM。它还抑制神经元一氧化氮合酶 (nNOS)/PSD-95 相互作用,并具有神经保护功效。 | |||
T14078 |
AB928
|
Adenosine Receptor | GPCR/G Protein; Neuroscience |
AB928 是可口服的选择性腺苷受体(A2aR/A2bR)双拮抗剂,可减轻腺苷介导的免疫抑制,具有免疫调节和抗肿瘤活性。 | |||
T8646 |
URB937
|
FAAH | Metabolism; Neuroscience |
URB937 是一种口服具有活性的、外周限制的FAAH 抑制剂,IC50=26.8 nM,可增加 anandamide 水平,但不能影响脑内 FAAH 水平 (无法透过血脑屏障)。 | |||
T13112L |
Tat-NR2B9c TFA
NA-1 (TFA) |
Others | Others |
Tat-NR2B9c TFA is a 20-aa peptide, and acts as an inhibitor of postsynaptic density-95 (PSD-95)(EC50 of 6.7 nM for PSD-95d2), and possesses neuroprotective efficacy. | |||
T31569 |
DP-b99
DP-b-99,DP-BAPTA-99,DPb-99,DPBAPTA-99,DP-b 99 |
||
DP-B 99 (DP-B 99, DP-BAPTA-99, DPB-99, DP-BAPTA-99) is a potential chelating agent for the treatment of acute pancreatitis. | |||
T81037 |
Tat-HA-NR2B9c
|
||
Tat-HA-NR2B9 是一种包括HIV-1 Tat细胞膜转导结构域片段、流感病毒血凝素(HA)表位标签以及NR2B(NR2B9c) C端9个氨基酸的化学复合物。该化合物能够降低大鼠缺血性脑损伤的梗塞面积,同时促进神经功能的恢复。 | |||
T22343 |
HKB99
|
Others | Others |
HKB99, an allosteric inhibitor of phosphoglycerate mutase 1, could suppresse tumor growth and metastasis and overcome erlotinib resistance in non-small-cell lung cancer (NSCLC) | |||
T13112 |
Tat-NR2B9c
Tat-NR2Bct,NA-1 |
NO Synthase; iGluR | Immunology/Inflammation; Membrane transporter/Ion channel; Neuroscience |
Tat-NR2B9c (NA-1) 是一种突触后密度-95(PSD-95)抑制剂,具有神经保护和抗癫痫作用。Tat-NR2B9c 可抑制PSD-95d2、 PSD-95d1 和 PSD-95,可阻止NMDA诱导的神经元NADPH氧化酶的激活,从而阻断超氧化物的产生,可减少中风后急性期的缺血性损伤。 | |||
T15484 |
HJB97
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
HJB97 可用于开发设计 PROTAC BET 的降解剂,具有抗肿瘤活性。HJB97 是高亲和力的 BET 抑制剂,Ki 值分别为 0.9 nM (BRD2 BD1),0.27 nM (BRD2 BD2),0.18 nM (BRD3 BD1),0.21 nM (BRD3 BD2),0.5 nM (BRD4 BD1),1.0 nM (BRD4 BD2)。 | |||
T77806 |
KRAS inhibitor FB9
|
||
KRAS inhibitor FB9 可用于 Ras 相关研究。 | |||
T32075 |
HH-Folic acid
|
||
HH-Folic acid derives from vitamin B9. | |||
T78930 |
T3SS-IN-1
|
||
T3SS-IN-1 (compound B9)为高效的III型分泌系统 (T3SS) 抑制剂,能够抑制hpa1启动子活性及harpin蛋白表达,但不干扰细菌生长。 | |||
T32705 |
Levomefolate magnesium
L-Methylfolate magnesium |
||
Levomefolate magnesium is the magnesium salt of the metabolite of folic acid (Vitamin B9) and it is a predominant active form of folate found in foods and in the blood circulation, accounting for 98% of folates in human plasma. It is transported across th |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T0062 |
Folic acid
Folate,Vitamin B9,Pteroylglutamic acid,Vitamin M,叶酸,Folacin |
DNA/RNA Synthesis; Endogenous Metabolite | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Metabolism |
Folic acid (Vitamin B9) 是维生素B9,是合成DNA/RNA,新细胞产生和维持的必要成分。 | |||
T21367 |
Tetrahydrofolic acid
5,6,7,8-tetrahydrofolic acid,folate-H4,Tetrahydropteroylglutamic acid,th-folate |
Endogenous Metabolite | Metabolism |
Tetrahydrofolic acid (5,6,7,8-tetrahydrofolic acid) 是一种维生素 B9 衍生物,是生物体常见的一碳供体,参与生物体生长代谢。 |